Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy

Journal of the Society for Gynecologic Investigation

Volumn 7, Issue 3, 2000, Pages 170-174

  Lambert Messerlian, Geralyn M ^e   Silver, Helayne M ^a   Petraglia, Felice ^b   Luisi, Stefano ^b   Pezzani, Ilaria ^a   Maybruck, Wendy M ^a   Hogge, W Allen ^c   Hanley Yanez, Karen ^c   Roberts, James M ^c   Neveux, Louis M ^d   Canick, Jacob A ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d FOUNDATION FOR BLOOD RESEARCH   (United States)

^e NONE

Author keywords

hCG; Inhibin; Preeclampsia; Pregnancy

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; THIRD TRIMESTER PREGNANCY;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL AGE; HUMANS; INHIBINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SENSITIVITY AND SPECIFICITY;

EID: 0034612174     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(00)00050-2     Document Type: Article

References (33)

1. Roberts J.M., Redman C.W.G. Pre-eclampsia More than pregnancy-induced hypertension . Lancet. 341:1993;1447-1454.
2. Roberts J.M. Prevention or early treatment of preeclampsia. N Engl J Med. 337:1997;124-125.
3. Walters B.N.J., Lao T., Smith V., DeSwiet M. α-Fetoprotein elevation and proteinuric pre-eclampsia. Br J Obstet Gynaecol. 92:1985;341-344.
4. Brazerol W.F., Grover S., Donnenfeld A.E. Unexplained elevated maternal serum α-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol. 171:1994;1030-1035.
5. Waller D.K., Lustig L.S., Cunningham G.C., Feuchtbaum L.B., Hook E.B. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol. 88:1996;816-822.
6. Benn P.A., Horne D., Briganti S., Rodis J.F., Clive J.M. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol. 87:1996;217-222.
7. Gonen R., Perez R., David M., Dar H., Merksamer R., Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol. 80:1992;83-86.
8. Sorensen T.K., Williams M.A., Zingheim R.W., Clement S.J., Hickok D.E. Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol. 169:1993;834-838.
9. Muller F., Savey L., LeFiblec B., Bussières L., Ndayizamba G., Colau J.C., et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol. 175:1996;37-40.
10. Liu D.F., Dickerman L.H., Redline R.W. Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels. Anat Pathol. 111:1999;209-215.
11. Wald N.J., Kennard A., Hackshaw A., McGuire A. Antenatal screening for Down's syndrome. J Med Screen. 4:1997;181-246.
12. Muttukrishna S., Knight P.G., Groome N.P., Redman C.W., Ledger W.L. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet. 349:1997;1285-1288.
13. Fraser R.F. II, McAsey M.E., Coney P. Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin. Am J Reprod Immunol. 40:1998;37-42.
14. Silver H.M., Lambert-Messerlian G.M., Star J.A., Hogan J., Canick J.A. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol. 180:1999;1131-1137.
15. Lambert-Messerlian G.M., Hall J.E., Sluss P.M., Taylor A.E., Martin K.A., Groome N.P., et al. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 79:1994;45-50.
16. King IB, Williams MA, Sorensen TK, Luthy DA. Inhibin A and activin A levels in the second trimester as predictors of preeclampsia [abstract]. Am J Obstet Gynecol 1998;178:S115.
17. Cuckle H., Sehmi I., Jones R. Maternal serum inhibin A can predict preeclampsia. Br J Obstet Gynaecol. 105:1998;1101-1103.
18. Aquilina J., Barnett A., Thompson O., Harrington K. Second-trimester maternal serum inhibin A concentrations as an early marker for preeclampsia. Am J Obstet Gynecol. 181:1999;131-136.
19. Räty R., Koskinen P., Alanen A., Irjala K., Matinlauri I., Ekblad U. Prediction of pre-eclampsia with mid-trimester total renin, inhibin A, AFP and free β-hCG levels. Prenat Diagn. 19:1999;122-127.
20. Sanchez-Ramos L., Sandroni S., Andres F.J., Kaunitz A.M. Calcium excretion in preeclampsia. Obstet Gynecol. 77:1991;510-514.
21. Baker P.N., Hackett G.A. The use of urinary albumin-creatinine ratios and calcium-creatinine ratios as a screening test for pregnancy-induced hypertension. Obstet Gynecol. 83:1994;745-749.
22. Paarlberg K.M., DeJong C.L.D., Van Geijn H.P.I., Van Kamp G.J., Heinen A.G.J.J., Dekker G.A. Total plasma fibronectin as a marker of pregnancy induced hypertensive disorders A longitudinal study . Obstet Gynecol. 91:1998;383-388.
23. Gredmark T., Bergman B., Hellstrom L. Total fibronectin in maternal plasma as a predictor for preeclampsia. Gynecol Obstet Invest. 47:1999;89-94.
24. Williams M.A., Farrand A., Mittendorf R., Sorensen T.K., Zingheim R.W., O'Reilly G.C., et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol. 149:1999;323-329.
25. Lim K.-H., Zhou Y., Janatpour M., McMaster M., Bass K., Chun S.-H., et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol. 151:1997;1809-1818.
26. Stallmach T., Hebisch G., Orban P., Lu X. Aberrant positioning of trophoblast and lymphocytes in the feto-maternal interface with pre-eclampsia. Virchows Arch. 434:1999;201-211.
27. Pouta A.M., Hartikainen A.-L., Vuolteenaho O.J., Ruokonen A.O., Laatikainen T.J. Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia. Obstet Gynecol. 91:1998;940-944.
28. Morssink L.P., Heringa M.P., Beekhuis J.R., DeWolf B.T.H.M., Mantingh A. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol. 89:1997;666-670.
29. Phillips O.P., Simpson J.L., Morgan C.D., Andersen R.N., Shulman L.P., Meyers C.M., et al. Unexplained elevated maternal serum α-fetoprotein is not predictive of adverse perinatal outcome in an indigent urban population. Am J Obstet Gynecol. 166:1992;978-982.
30. Pergament E., Stein A.K., Fiddler M., Cho N.H., Kupfermine M.J. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol. 86:1995;255-258.
31. Dungan J.S., Shulman L.P., Phillips O.P., Simpson J.L., Meyer N.L., Grevengood C., et al. Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in the absence of fetal aneuploidy. J Soc Gynecol Invest. 1:1994;55-58.
32. Rosing U., Carlstrom K. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest. 18:1984;199-205.
33. Myatt L., Miodovnik M. Prediction of preeclampsia. Semin Perinatol. 23:1999;45-57.